Structure

Physi-Chem Properties

Molecular Weight:  580.14
Volume:  526.232
LogP:  -0.28
LogD:  -0.48
LogS:  -2.167
# Rotatable Bonds:  6
TPSA:  260.2
# H-Bond Aceptor:  15
# H-Bond Donor:  10
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.15
Synthetic Accessibility Score:  4.695
Fsp3:  0.423
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.469
MDCK Permeability:  1.804949170036707e-05
Pgp-inhibitor:  0.012
Pgp-substrate:  0.984
Human Intestinal Absorption (HIA):  0.879
20% Bioavailability (F20%):  0.09
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.075
Plasma Protein Binding (PPB):  76.38166046142578%
Volume Distribution (VD):  0.712
Pgp-substrate:  17.540090560913086%

ADMET: Metabolism

CYP1A2-inhibitor:  0.033
CYP1A2-substrate:  0.015
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.115
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.126
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.004

ADMET: Excretion

Clearance (CL):  1.267
Half-life (T1/2):  0.704

ADMET: Toxicity

hERG Blockers:  0.415
Human Hepatotoxicity (H-HT):  0.207
Drug-inuced Liver Injury (DILI):  0.981
AMES Toxicity:  0.753
Rat Oral Acute Toxicity:  0.043
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.509
Carcinogencity:  0.077
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.015

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472607

Natural Product ID:  NPC472607
Common Name*:   SIQKOOPSNYYQBQ-XGTPRPFSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  SIQKOOPSNYYQBQ-XGTPRPFSSA-N
Standard InCHI:  InChI=1S/C26H28O15/c27-6-12-17(32)21(36)23(39-12)15-18(33)14-10(30)5-11(8-1-3-9(29)4-2-8)38-24(14)25(19(15)34)41-26-22(37)20(35)16(31)13(7-28)40-26/h1-5,12-13,16-17,20-23,26-29,31-37H,6-7H2/t12-,13-,16+,17-,20+,21+,22-,23+,26+/m1/s1
SMILES:  C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)C5C(C(C(O5)CO)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581068
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003540] Flavonoid-8-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota stem bark Indonesia 1999-SEP PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. stem n.a. PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota dry stem n.a. n.a. PMID[25466192]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota Roots n.a. n.a. PMID[29482940]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 > 100000.0 nM PMID[514271]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472607 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9691 High Similarity NPC58716
0.9691 High Similarity NPC146792
0.9691 High Similarity NPC45618
0.9639 High Similarity NPC168584
0.9634 High Similarity NPC205076
0.9634 High Similarity NPC307518
0.9634 High Similarity NPC48773
0.9632 High Similarity NPC201292
0.9632 High Similarity NPC475942
0.9632 High Similarity NPC105025
0.9632 High Similarity NPC93337
0.9632 High Similarity NPC186807
0.9632 High Similarity NPC469931
0.9632 High Similarity NPC45638
0.9632 High Similarity NPC471457
0.9632 High Similarity NPC226294
0.9632 High Similarity NPC58053
0.9632 High Similarity NPC170675
0.9632 High Similarity NPC112755
0.9573 High Similarity NPC282987
0.9573 High Similarity NPC183357
0.9573 High Similarity NPC224462
0.9573 High Similarity NPC22195
0.9573 High Similarity NPC34287
0.9573 High Similarity NPC105511
0.9573 High Similarity NPC471416
0.9573 High Similarity NPC245014
0.9573 High Similarity NPC21190
0.9573 High Similarity NPC84265
0.9515 High Similarity NPC172807
0.9515 High Similarity NPC235575
0.9515 High Similarity NPC211594
0.9515 High Similarity NPC3583
0.9515 High Similarity NPC476405
0.9515 High Similarity NPC259152
0.9515 High Similarity NPC117260
0.9515 High Similarity NPC256760
0.9515 High Similarity NPC254540
0.9512 High Similarity NPC210042
0.9512 High Similarity NPC472381
0.9512 High Similarity NPC472383
0.9512 High Similarity NPC95855
0.9512 High Similarity NPC471287
0.9506 High Similarity NPC470178
0.9506 High Similarity NPC270335
0.9506 High Similarity NPC191306
0.9461 High Similarity NPC257714
0.9458 High Similarity NPC101026
0.9458 High Similarity NPC45522
0.9458 High Similarity NPC21666
0.9458 High Similarity NPC204693
0.9458 High Similarity NPC239549
0.9458 High Similarity NPC236191
0.9458 High Similarity NPC24043
0.9458 High Similarity NPC208668
0.9458 High Similarity NPC42773
0.9458 High Similarity NPC169977
0.9458 High Similarity NPC51774
0.9455 High Similarity NPC150767
0.9455 High Similarity NPC44558
0.9455 High Similarity NPC78734
0.9455 High Similarity NPC218488
0.9455 High Similarity NPC474434
0.9455 High Similarity NPC212748
0.9451 High Similarity NPC93099
0.9451 High Similarity NPC45400
0.9451 High Similarity NPC229729
0.9451 High Similarity NPC471288
0.9451 High Similarity NPC42892
0.9451 High Similarity NPC135345
0.9451 High Similarity NPC477502
0.9448 High Similarity NPC165720
0.9448 High Similarity NPC311830
0.9448 High Similarity NPC22832
0.9444 High Similarity NPC77660
0.9444 High Similarity NPC189142
0.9412 High Similarity NPC148710
0.9408 High Similarity NPC473071
0.9408 High Similarity NPC473073
0.9401 High Similarity NPC43211
0.9401 High Similarity NPC477848
0.9401 High Similarity NPC115760
0.9401 High Similarity NPC237435
0.9401 High Similarity NPC135277
0.9401 High Similarity NPC49344
0.9401 High Similarity NPC210094
0.9401 High Similarity NPC101191
0.9398 High Similarity NPC475825
0.9398 High Similarity NPC301683
0.9398 High Similarity NPC261254
0.9398 High Similarity NPC267254
0.9398 High Similarity NPC223375
0.9398 High Similarity NPC472386
0.9394 High Similarity NPC183036
0.9394 High Similarity NPC229687
0.939 High Similarity NPC5778
0.939 High Similarity NPC236934
0.939 High Similarity NPC99957
0.939 High Similarity NPC181616
0.939 High Similarity NPC21100
0.939 High Similarity NPC254306
0.939 High Similarity NPC197285
0.9387 High Similarity NPC88023
0.9387 High Similarity NPC284960
0.9387 High Similarity NPC168822
0.9387 High Similarity NPC19709
0.9387 High Similarity NPC309025
0.9387 High Similarity NPC88043
0.9387 High Similarity NPC222936
0.9387 High Similarity NPC243930
0.9387 High Similarity NPC29830
0.9387 High Similarity NPC94777
0.9353 High Similarity NPC473072
0.9345 High Similarity NPC211532
0.9345 High Similarity NPC233994
0.9345 High Similarity NPC268533
0.9345 High Similarity NPC8573
0.9345 High Similarity NPC472991
0.9345 High Similarity NPC198324
0.9345 High Similarity NPC169733
0.9345 High Similarity NPC472992
0.9345 High Similarity NPC472385
0.9337 High Similarity NPC231194
0.9337 High Similarity NPC72249
0.9337 High Similarity NPC51326
0.9329 High Similarity NPC470773
0.9329 High Similarity NPC277205
0.9325 High Similarity NPC125991
0.9325 High Similarity NPC127782
0.9325 High Similarity NPC300537
0.9325 High Similarity NPC473043
0.9298 High Similarity NPC49690
0.929 High Similarity NPC476618
0.929 High Similarity NPC476623
0.929 High Similarity NPC476620
0.929 High Similarity NPC476622
0.929 High Similarity NPC469600
0.929 High Similarity NPC476621
0.929 High Similarity NPC476619
0.9286 High Similarity NPC264735
0.9286 High Similarity NPC108202
0.9286 High Similarity NPC142996
0.9286 High Similarity NPC294629
0.9286 High Similarity NPC102028
0.9281 High Similarity NPC156977
0.9281 High Similarity NPC475155
0.9281 High Similarity NPC245452
0.9277 High Similarity NPC86008
0.9277 High Similarity NPC209296
0.9277 High Similarity NPC219904
0.9277 High Similarity NPC203050
0.9277 High Similarity NPC120099
0.9277 High Similarity NPC195257
0.9277 High Similarity NPC223747
0.9277 High Similarity NPC225434
0.9273 High Similarity NPC253662
0.9273 High Similarity NPC308404
0.9273 High Similarity NPC210073
0.9273 High Similarity NPC179950
0.9273 High Similarity NPC115674
0.9273 High Similarity NPC145038
0.9273 High Similarity NPC67037
0.9273 High Similarity NPC118284
0.9273 High Similarity NPC8856
0.9273 High Similarity NPC274618
0.9273 High Similarity NPC56077
0.9273 High Similarity NPC276222
0.9273 High Similarity NPC255615
0.9273 High Similarity NPC281131
0.9273 High Similarity NPC88789
0.9268 High Similarity NPC127415
0.9268 High Similarity NPC470772
0.9264 High Similarity NPC182045
0.9264 High Similarity NPC26326
0.9264 High Similarity NPC162668
0.9259 High Similarity NPC117418
0.9259 High Similarity NPC53545
0.924 High Similarity NPC473883
0.9235 High Similarity NPC126784
0.9235 High Similarity NPC110941
0.9235 High Similarity NPC473571
0.9235 High Similarity NPC473682
0.9235 High Similarity NPC470444
0.9235 High Similarity NPC470443
0.9235 High Similarity NPC241423
0.9231 High Similarity NPC156635
0.9231 High Similarity NPC472380
0.9231 High Similarity NPC470949
0.9231 High Similarity NPC65563
0.9231 High Similarity NPC472382
0.9231 High Similarity NPC255799
0.9231 High Similarity NPC472384
0.9226 High Similarity NPC25724
0.9226 High Similarity NPC4390
0.9222 High Similarity NPC177731
0.9222 High Similarity NPC105095
0.9222 High Similarity NPC206123
0.9222 High Similarity NPC20505
0.9222 High Similarity NPC79056
0.9222 High Similarity NPC285197

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472607 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9571 High Similarity NPD3818 Discontinued
0.9401 High Similarity NPD4338 Clinical (unspecified phase)
0.9277 High Similarity NPD7054 Approved
0.9222 High Similarity NPD7472 Approved
0.9222 High Similarity NPD7074 Phase 3
0.908 High Similarity NPD4381 Clinical (unspecified phase)
0.9053 High Similarity NPD6797 Phase 2
0.9 High Similarity NPD7251 Discontinued
0.8947 High Similarity NPD7808 Phase 3
0.8896 High Similarity NPD2801 Approved
0.8896 High Similarity NPD2393 Clinical (unspecified phase)
0.8834 High Similarity NPD1934 Approved
0.8824 High Similarity NPD7804 Clinical (unspecified phase)
0.8757 High Similarity NPD6166 Phase 2
0.8757 High Similarity NPD6167 Clinical (unspecified phase)
0.8757 High Similarity NPD6168 Clinical (unspecified phase)
0.8743 High Similarity NPD5494 Approved
0.8712 High Similarity NPD4380 Phase 2
0.8671 High Similarity NPD6559 Discontinued
0.8563 High Similarity NPD4868 Clinical (unspecified phase)
0.8563 High Similarity NPD3882 Suspended
0.8457 Intermediate Similarity NPD1511 Approved
0.8393 Intermediate Similarity NPD3817 Phase 2
0.8354 Intermediate Similarity NPD1512 Approved
0.8294 Intermediate Similarity NPD7075 Discontinued
0.8286 Intermediate Similarity NPD5844 Phase 1
0.8284 Intermediate Similarity NPD5402 Approved
0.8253 Intermediate Similarity NPD1653 Approved
0.8192 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD6801 Discontinued
0.8142 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD7228 Approved
0.8118 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8103 Intermediate Similarity NPD6232 Discontinued
0.8086 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7473 Discontinued
0.8046 Intermediate Similarity NPD1247 Approved
0.8037 Intermediate Similarity NPD1549 Phase 2
0.8035 Intermediate Similarity NPD6234 Discontinued
0.8033 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7819 Suspended
0.8012 Intermediate Similarity NPD1465 Phase 2
0.8 Intermediate Similarity NPD7411 Suspended
0.7976 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7967 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7956 Intermediate Similarity NPD8312 Approved
0.7956 Intermediate Similarity NPD8313 Approved
0.7953 Intermediate Similarity NPD37 Approved
0.7944 Intermediate Similarity NPD7685 Pre-registration
0.7943 Intermediate Similarity NPD7199 Phase 2
0.7943 Intermediate Similarity NPD6959 Discontinued
0.7919 Intermediate Similarity NPD4967 Phase 2
0.7919 Intermediate Similarity NPD4965 Approved
0.7919 Intermediate Similarity NPD4966 Approved
0.787 Intermediate Similarity NPD5403 Approved
0.7853 Intermediate Similarity NPD1510 Phase 2
0.7842 Intermediate Similarity NPD6780 Approved
0.7842 Intermediate Similarity NPD6778 Approved
0.7842 Intermediate Similarity NPD6781 Approved
0.7842 Intermediate Similarity NPD6782 Approved
0.7842 Intermediate Similarity NPD6777 Approved
0.7842 Intermediate Similarity NPD6779 Approved
0.7842 Intermediate Similarity NPD6776 Approved
0.7829 Intermediate Similarity NPD919 Approved
0.7821 Intermediate Similarity NPD3751 Discontinued
0.7805 Intermediate Similarity NPD2796 Approved
0.7797 Intermediate Similarity NPD3787 Discontinued
0.7753 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD5401 Approved
0.772 Intermediate Similarity NPD7435 Discontinued
0.7716 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD1613 Approved
0.7709 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD7584 Approved
0.7692 Intermediate Similarity NPD6799 Approved
0.767 Intermediate Similarity NPD3749 Approved
0.7654 Intermediate Similarity NPD3926 Phase 2
0.765 Intermediate Similarity NPD7240 Approved
0.7647 Intermediate Similarity NPD2534 Approved
0.7647 Intermediate Similarity NPD2533 Approved
0.7647 Intermediate Similarity NPD2532 Approved
0.7629 Intermediate Similarity NPD7697 Approved
0.7629 Intermediate Similarity NPD7698 Approved
0.7629 Intermediate Similarity NPD7696 Phase 3
0.7626 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD7783 Phase 2
0.7614 Intermediate Similarity NPD8151 Discontinued
0.7607 Intermediate Similarity NPD943 Approved
0.76 Intermediate Similarity NPD8455 Phase 2
0.759 Intermediate Similarity NPD7870 Phase 2
0.759 Intermediate Similarity NPD2935 Discontinued
0.759 Intermediate Similarity NPD7871 Phase 2
0.7579 Intermediate Similarity NPD6535 Approved
0.7579 Intermediate Similarity NPD6534 Approved
0.7577 Intermediate Similarity NPD6823 Phase 2
0.7563 Intermediate Similarity NPD7701 Phase 2
0.756 Intermediate Similarity NPD2800 Approved
0.7558 Intermediate Similarity NPD920 Approved
0.7544 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6599 Discontinued
0.7515 Intermediate Similarity NPD3750 Approved
0.7515 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7768 Phase 2
0.75 Intermediate Similarity NPD1240 Approved
0.7487 Intermediate Similarity NPD7874 Approved
0.7487 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD6190 Approved
0.7469 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7700 Phase 2
0.7461 Intermediate Similarity NPD7699 Phase 2
0.745 Intermediate Similarity NPD7801 Approved
0.744 Intermediate Similarity NPD7266 Discontinued
0.7427 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD3027 Phase 3
0.7419 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1607 Approved
0.7407 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD8434 Phase 2
0.7353 Intermediate Similarity NPD1243 Approved
0.7353 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD230 Phase 1
0.7349 Intermediate Similarity NPD1933 Approved
0.7344 Intermediate Similarity NPD6213 Phase 3
0.7344 Intermediate Similarity NPD6212 Phase 3
0.7344 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5953 Discontinued
0.731 Intermediate Similarity NPD4628 Phase 3
0.73 Intermediate Similarity NPD7585 Approved
0.7278 Intermediate Similarity NPD1551 Phase 2
0.7273 Intermediate Similarity NPD3226 Approved
0.7273 Intermediate Similarity NPD7680 Approved
0.7273 Intermediate Similarity NPD2313 Discontinued
0.7263 Intermediate Similarity NPD8150 Discontinued
0.7251 Intermediate Similarity NPD6674 Discontinued
0.725 Intermediate Similarity NPD7583 Approved
0.7246 Intermediate Similarity NPD447 Suspended
0.7241 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD3748 Approved
0.7216 Intermediate Similarity NPD4360 Phase 2
0.7216 Intermediate Similarity NPD4363 Phase 3
0.7213 Intermediate Similarity NPD5711 Approved
0.7213 Intermediate Similarity NPD5710 Approved
0.7204 Intermediate Similarity NPD7286 Phase 2
0.7175 Intermediate Similarity NPD7458 Discontinued
0.7169 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6844 Discontinued
0.715 Intermediate Similarity NPD8320 Phase 1
0.715 Intermediate Similarity NPD8319 Approved
0.7135 Intermediate Similarity NPD2344 Approved
0.7135 Intermediate Similarity NPD2346 Discontinued
0.7129 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD2799 Discontinued
0.7118 Intermediate Similarity NPD7033 Discontinued
0.7118 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6651 Approved
0.7087 Intermediate Similarity NPD7930 Approved
0.7086 Intermediate Similarity NPD7390 Discontinued
0.7079 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD5006 Approved
0.705 Intermediate Similarity NPD5005 Approved
0.7045 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD8059 Phase 3
0.7041 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD5124 Phase 1
0.7037 Intermediate Similarity NPD1091 Approved
0.703 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD7229 Phase 3
0.7018 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD4361 Phase 2
0.7005 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.6994 Remote Similarity NPD2424 Discontinued
0.6988 Remote Similarity NPD2861 Phase 2
0.6988 Remote Similarity NPD9494 Approved
0.6977 Remote Similarity NPD6100 Approved
0.6977 Remote Similarity NPD6099 Approved
0.6973 Remote Similarity NPD8127 Discontinued
0.6971 Remote Similarity NPD2309 Approved
0.6952 Remote Similarity NPD4665 Approved
0.6952 Remote Similarity NPD4111 Phase 1
0.6946 Remote Similarity NPD4908 Phase 1
0.6935 Remote Similarity NPD4420 Approved
0.6933 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6928 Remote Similarity NPD2798 Approved
0.6914 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6898 Remote Similarity NPD5242 Approved
0.6887 Remote Similarity NPD7907 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data